Clinical Trials Directory

Trials / Completed

CompletedNCT03994640

Myorelaxant Effect of Cannabis Cream Topical Skin Application in Patients With TMD

Myorelaxant Effect of Cannabis Cream Topical Skin Application in Patients With Temporomandibular Disorders: a Randomized, Double-blind Study

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Medical University of Silesia · Academic / Other
Sex
All
Age
22 Years – 27 Years
Healthy volunteers
Accepted

Summary

Evaluation of myorelaxant effect of cannabis cream.compared to placebo cream in topical skin application in patients with TMD

Detailed description

Cannabis sativa has a very wide application in various fields of medicine. In patients with temporomandibular disorder, especially with myofascial pain of masticatory muscles there is a special need to seek an effective pain therapy and muscle relaxing methods. Patients with TMD suffer from chronic pain and depression, cannabis topical skin application therapy seems promising in that field. Patients attending The Department of TMD in Zabrze, Polska were randomly divided into two groups: experimental and placebo. sEMG activity values were compared during 14 days therapy with cream. Positive results were obtained confirming the efficacy of the cannabis cream used in the study, compared to placebo.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTCannabis CreamTopical, bilateral skin application of cannabis cream with self-massage of masseter muscles
COMBINATION_PRODUCTPlacebo CreamTopical, bilteral skin application of placebo cream with self-massage of masseter muscles

Timeline

Start date
2018-01-01
Primary completion
2018-10-01
Completion
2019-01-01
First posted
2019-06-21
Last updated
2019-06-21

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT03994640. Inclusion in this directory is not an endorsement.